Literature DB >> 35355759

Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.

S P Pakhomov1, V S Orlova1, I N Verzilina1, N V Sukhih1, A V Nagorniy1, A V Matrosova2.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is the most severe and life-threatening complication of assisted reproductive technologies (ART). OHSS is based on an excessive ovarian response to ovarian stimulation; however, the pathogenesis has not been fully understood yet. The most serious complications of OHSS are thromboembolic complications and ovarian torsion. The current study describes the risk factors for the development of ovarian hyperstimulation syndrome and proposes a method for specific prediction of this syndrome. This study was designed to investigate 671 therapeutic cycles in the IVF program during 2009-2018. All patients were divided into two groups. Group one (n=56) included women who developed OHSS during the IVF procedure. Group two (n=615) consisted of women who did not have this complication during the IVF procedure. All the observation and examination outcomes were entered into a specially developed questionnaire, and then into a Microsoft Excel spreadsheet. The data were processed by variable statistics using Statistica 10.0. Analyzing of the recorded data revealed that the rate of OHSS was higher in the group of younger women, aged 30.76±3.67 years, in comparison with those aged 32.78±4.40 years in the group of patients without OHSS (p<0.05). The analysis of the initial phase of the reproductive system has confirmed that the group of patients with OHSS had a higher level of prolactin, 462.84±191.56 mIU/L in comparison with 363.43±187.84 mIU/L, which corresponded to the group of women without OHSS (p<0.05). In our results, 7.15±1.04% of cases with OHSS had obesity, while of the patients from the group without OHSS suffered from it (p<0.05). OHSS is the most severe iatrogenic complication of ART, therefore it is extremely important to consider its risk factors and take timely preventive measures. This study has established a high relationship between the studied risk factors and ovarian hyperstimulation syndrome and proposed a model for predicting this syndrome.

Entities:  

Keywords:  Hyperstimulation Syndrome; Infertility; Ovarian; Pregnancy; in Vitro Fertilization

Mesh:

Year:  2021        PMID: 35355759      PMCID: PMC8934082          DOI: 10.22092/ari.2021.355581.1700

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  37 in total

1.  Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.

Authors:  Tsung-Hsien Lee; Chung-Hsien Liu; Chuin-Chia Huang; Yi-Ling Wu; Yang-Tse Shih; Hong-Nerng Ho; Yu-Shih Yang; Maw-Shang Lee
Journal:  Hum Reprod       Date:  2007-11-13       Impact factor: 6.918

2.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

Review 3.  Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.

Authors:  Mohamed A Youssef; Ahmed M Abou-Setta; Wai Sun Lam
Journal:  Cochrane Database Syst Rev       Date:  2016-04-23

Review 4.  Ovarian hyperstimulation syndrome.

Authors:  Marie M Budev; Alejandro C Arroliga; Tommaso Falcone
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

5.  A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome.

Authors:  M Al-Ramahi; A Leader; P Claman; J Spence
Journal:  Hum Reprod       Date:  1997-12       Impact factor: 6.918

Review 6.  Cabergoline for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Tamara Hunter; Yongfang Hu; Suo-Di Zhai; Xiaoyan Sheng; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

7.  An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome.

Authors:  Vittorio Fineschi; Margherita Neri; Sabina Di Donato; Cristoforo Pomara; Irene Riezzo; Emanuela Turillazzi
Journal:  Int J Legal Med       Date:  2006-06-02       Impact factor: 2.686

8.  Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles.

Authors:  J Blankstein; J Shalev; T Saadon; E E Kukia; J Rabinovici; C Pariente; B Lunenfeld; D M Serr; S Mashiach
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

Review 9.  Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.

Authors:  Sérgio Reis Soares; Raúl Gómez; Carlos Simón; Juan Antonio García-Velasco; Antonio Pellicer
Journal:  Hum Reprod Update       Date:  2008-04-02       Impact factor: 15.610

View more
  1 in total

Review 1.  The Treatment of Complementary and Alternative Medicine on Female Infertility Caused by Endometrial Factors.

Authors:  Jing Lin; Haoyue Ma; Hang Li; Jing Han; Tingting Guo; Zhen Qin; Liyan Jia; Yuehui Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.